Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2–mediated angiogenesis

Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2–mediated angiogenesis

Several studies have revealed the potential of normalizing tumor vessels in anti-angiogenic treatment. Recombinant human endostatin is an anti-angiogenic agent which has been applied in clinical tumor treatment. Our previous research indicated that gold nanoparticles could be a nanoparticle carrier...

Full description

Bibliographic Details
Main Authors:	Fan Pan, Wende Yang, Wei Li, Xiao-Yan Yang, Shuhao Liu, Xin Li, Xiaoxu Zhao, Hui Ding, Li Qin, Yunlong Pan
Format:	Article
Language:	English
Published:	IOS Press 2017-07-01
Series:	Tumor Biology
Online Access:	https://doi.org/10.1177/1010428317708547

Similar Items

Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
by: Xingqun Ma, et al.
Published: (2012-01-01)

Angiogenesis and expression of vascular endothelial growth factor and endostatin protein in myocardial infarction rat model
by: Chenglong Zheng, et al.
Published: (2016-02-01)

Studies on the Inhibitory Mechanism of Angiogenesis Inhibitor, endostatin
by: 陳恒琦
Published: (2000)

Studies on the Inhibitory Mechanism of Angiogenesis Inhibitor, Endostatin
by: Chen Heng-Chi, James, et al.
Published: (2000)

Studies on the Inhibitory Mechanism of Angiogenesis Inhibitor, Endostatin
by: Heng-Chi Chen, et al.

Clinical evaluation of vascular normalization induced by recombinant human endostatin in nasopharyngeal carcinoma via dynamic contrast-enhanced ultrasonography
by: Yang Z, et al.
Published: (2018-11-01)

Application progress of recombinant human endostatin in the treatment of head and neck cancer
by: LI Xiaodong, et al.
Published: (2020-04-01)

Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway.
by: Xiaoming Xu, et al.
Published: (2014-01-01)

Inhibition of the recombinant human endostatin adenavirus on experimental choroidal neovascularization in rats
by: Li-Juan Chen, et al.
Published: (2017-06-01)

Recombinant Human Endostatin in the Treatment of Advanced Lung Squamous Cell Carcinoma
by: Puyuan XING, et al.
Published: (2016-10-01)

Isolation and study of bioactivities study of the recombinant human endostatin
by: E. S. Kalinina, et al.
Published: (2006-02-01)

Effects of recombinant human endostatin on therapeutic effect, angiogenesis, tumor cell proliferation and migration in patients with non-small cell lung cancer
by: Min-Wen Ling
Published: (2019-01-01)

Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)

Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)

Effect of continuous recombinant human endostatin pumping combined with TP chemotherapy on serum malignant molecules and angiogenesis molecules in patients with advanced ovarian cancer
by: Wei-Dong Chen
Published: (2017-05-01)

Effect of an incremental aerobic training program on improving angiogenesis and balance in vascular endothelial growth factor and endostatinic in male rats with myocardial infarction
by: MalekiPoya M, et al.
Published: (2019-10-01)

Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth
by: Ke Zhang, et al.
Published: (2017-12-01)

The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
by: Liu YY, et al.
Published: (2016-10-01)

Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
by: Zhang Q, et al.
Published: (2016-12-01)

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
by: Joanna Gora-Tybor, et al.
Published: (2003-01-01)

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis
by: Junko Yoshida, et al.
Published: (2015-01-01)

Clinical Observation of Recombinant Human Vascular Endostatin Durative Transfusion Combined with Window Period Arterial Infusion Chemotherapy in the Treatment of  Advanced Lung Squamous Carcinoma
by: Yuan LV, et al.
Published: (2015-08-01)

Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis
by: Li Feng, et al.
Published: (2021-02-01)

Endostatin in Renal and Cardiovascular Diseases
by: Mei Li, et al.
Published: (2021-09-01)

Cloning and Expression of Recombinant Human Endostatin in Periplasm of Escherichia coli Expression System
by: Abbas Mohajeri, et al.
Published: (2016-06-01)

Effects of vascular endothelial growth factor (VEGF-A) and endostatin on bone
by: Sipola, A. (Annina)
Published: (2009)

Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
by: Shan Wang, et al.
Published: (2016-01-01)

Enhancement of Recombinant Human Endostatin on the Radiosensitivity of Human Pulmonary Adenocarcinoma A549 Cells and Its Mechanism
by: Xiao-dong Jiang, et al.
Published: (2012-01-01)

Effects of Recombinant Human Endostatin and Docetaxel on MMP and its Following Anti-neoplastic Effect under Different Administration Sequences
by: Jing YUAN, et al.
Published: (2010-06-01)

The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering
by: Abbas Mohajeri, et al.
Published: (2017-04-01)

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study
by: Jing-jing Ge, et al.
Published: (2020-01-01)

Recombined humanized endostatin‐induced suppression of HMGB1 expression inhibits proliferation of NSCLC cancer cells
by: Fan‐Jie Meng, et al.
Published: (2019-01-01)

Clinical Value of 99mTc-3PRGD2 Molecular Image in Evaluating Effect of Recombinant Endostatin
by: YANG Zhenhua, et al.
Published: (2018-05-01)

Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
by: Fang Peng, et al.
Published: (2012-01-01)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
by: Chunhai Fan, et al.
Published: (2007-01-01)

The measurement of vascular endothelial growth factor-A, endostatin and neuropilin-1 in colorectal cancer
by: Easterbrook, Jonathan Richard
Published: (2004)

Erratum: Clinical Observation of Recombinant Human Vascular Endostatin Durative Transfusion Combined with Window Period Arterial Infusion Chemotherapy in the Treatment of Advanced Lung Squamous Carcinoma
by: Editorial Office of Chinese Journal of Lung Cancer
Published: (2016-03-01)

Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin
by: Yan-hui Gu, et al.
Published: (2021-09-01)

Interrupted aortic arch with multiple vascular malformations
by: Xiao-Rui Xiang, et al.
Published: (2019-10-01)

Clinical observation and therapeutic evaluation of intravenous pump of recombinant human endostatin combined with TP regimen in treating patients with advanced ovarian cancer
by: Chi Zhang, et al.
Published: (2015-09-01)